Medication info

Rotenal 50 mg (Atenolol)

Prescription medicationApproval withdrawn
Ingredient · strength
Atenolol›Strength being verified
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
It is a white round film-coated tablet.
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 198600233 · Notified 1986.12.22

This product's status changed to Approval withdrawn on 2023.07.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of angina and hypertension
Who uses it
Adults
Adult dosage
1. Hypertension The initial adult dose is 50㎎ of atenolol once daily, administered orally alone or in combination with a diuretic (thiazide type). If an effect is not seen within 1-2 weeks, increase the dose to 100㎎ once daily. Do not exceed 100㎎ per day. 2. Angina Administer 100㎎ of this drug daily in 1-2 divided doses. Do not exceed 100㎎ per day. 3. Patients with renal impairment Creatinine clearance (㎖/min/1.73㎡) 15-35: 50㎎ daily Creatinine clearance (㎖/min/1.73㎡) <15: 25㎎ daily or 50㎎ every 2 days Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of angina and hypertension

  • Hypertension
  • angina
View approved original text

This medication is used for hypertension and angina.

Dosage and Administration

Adult dosage

1. Hypertension The initial adult dose is 50㎎ of atenolol once daily, administered orally alone or in combination with a diuretic (thiazide type). If an effect is not seen within 1-2 weeks, increase the dose to 100㎎ once daily. Do not exceed 100㎎ per day. 2. Angina Administer 100㎎ of this drug daily in 1-2 divided doses. Do not exceed 100㎎ per day. 3. Patients with renal impairment Creatinine clearance (㎖/min/1.73㎡) 15-35: 50㎎ daily Creatinine clearance (㎖/min/1.73㎡) <15: 25㎎ daily or 50㎎ every 2 days Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used by individuals allergic to the active ingredient or excipients. It should not be administered to patients with severe bronchial asthma or chronic lung disease. This medication may pose risks to patients with diabetic ketoacidosis or metabolic acidosis. It should not be used in patients with very slow heart rates (bradycardia) or cardiac conduction disorders. Patients with cardiogenic shock or heart failure due to pulmonary hypertension or congestive heart failure should avoid this medication. It is unsuitable for patients with severe hypotension or significant peripheral vascular disease. Caution is required for patients at risk of thyroid storm due to thyroid dysfunction. It should not be used in untreated chromaffin cell tumor patients. In patients with bronchial asthma or those at risk of bronchospasm, bronchodilators should be used concomitantly with this medication, and careful monitoring is necessary. Patients at risk of heart failure should be carefully monitored while on this medication. Diabetic patients must closely manage their blood sugar, as symptoms of hypoglycemia may be masked. Dose adjustments and cautious administration are required for patients with significantly impaired liver or kidney function. Elderly patients should start at a low dose and be monitored closely. This medication can cause various side effects; if rash, itching, dry eyes or vision changes, heart rate changes, mental changes, digestive disturbances, or breathing difficulties occur, notify your provider immediately and discontinue use. Regular monitoring of cardiac function, blood pressure, and pulse is critical during long-term use, as abrupt discontinuation may worsen heart disease; tapering is recommended. Patients scheduled for surgery should stop this medication 24 hours prior and inform the anesthesiologist of its use. Caution is needed when driving or operating machinery due to potential side effects like dizziness. This medication has many interactions with other drugs, especially antihypertensives, antidiabetic drugs, heart medications, and anesthetics; consult with a physician or pharmacist before use. Pregnant or breastfeeding women should carefully consider the potential effects on the fetus or neonate before using this medication. Safety in pediatric patients has not been established; use caution when administering to children. In case of overdose, symptoms like decreased heart rate, heart failure, hypotension, bronchospasm, or hypoglycemia may occur, and immediate medical attention is required. Store this medication out of reach of children and avoid exposure to temperatures above 25 degrees Celsius.

Side effects

  • Rash
  • itching
  • vascular swelling
  • hives
  • decreased tear secretion
  • blurred vision
  • visual impairment
  • dry eyes
  • bradycardia
  • cold extremities
Show 88 more
  • palpitations
  • increased heart size
  • chest tightness
  • hypotension
  • cold sensation in limbs
  • atrioventricular block
  • sinus block
  • orthostatic hypotension
  • leg pain
  • heart failure
  • exacerbation of heart block
  • intermittent claudication
  • Raynaud's phenomenon
  • confusion
  • mood changes
  • nightmares
  • psychiatric disorders
  • hallucinations
  • sleep disturbances
  • heaviness in the head
  • dizziness
  • orthostatic dysregulation
  • insomnia
  • drowsiness
  • congestive state
  • ringing in the ears
  • tinnitus
  • ear pain
  • fatigue
  • weakness
  • lethargy
  • headache
  • sensory disturbances
  • consciousness impairment
  • gastrointestinal disorders
  • thirst
  • nausea
  • vomiting
  • loss of appetite
  • abdominal discomfort
  • diarrhea
  • loose stools
  • constipation
  • abdominal pain
  • wheezing
  • shortness of breath
  • bronchospasm
  • bronchial spasm
  • elevated AST
  • elevated ALT
  • intrahepatic cholestasis
  • elevated BUN
  • elevated creatinine
  • urticaria
  • psoriasis
  • psoriatic urticaria
  • alopecia
  • purpura
  • thrombocytopenia
  • erectile dysfunction
  • numbness
  • edema
  • peripheral edema
  • sweating
  • coolness
  • frequent urination
  • increased transaminase levels
  • hyperlipidemia
  • hyperglycemia
  • hyperuricemia
  • elevated CPK
  • agranulocytosis
  • non-thrombocytopenic purpura
  • thrombocytopenic purpura
  • tonsillitis
  • laryngospasm
  • respiratory distress
  • liver disease
  • vision disorders
  • loss of orientation
  • short-term memory loss
  • emotional instability
  • neuropsychiatric disorders
  • mesenteric artery thrombosis
  • ischemic colitis
  • reversible alopecia
  • Peyronie's disease
  • erythematous rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture ingress. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and safety.

Appearance and packaging

Appearance

It is a white round film-coated tablet.

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.